Home → Best Practices

Best Practices
Amgen Cuts Repatha's Price 60% as Scrutiny of Drug Costs Heats Up Print E-mail
Written by FHI's Week in Review   
Monday, 29 October 2018 11:03
Patrice Wendling reports for Medscape on October 24, 2018:
Amgen announced today it is lowering the cost of its cholesterol-lowering drug, evolocumab ( Repatha), by roughly 60%. The move was designed to increase demand by lowering out-of-pocket costs, especially for Medicare patients, who currently pay between $280 and $370 a month in out-of-pocket costs, but will now pay $25 to $150 a month, Amgen officials said in a telephone press briefing.
Read more in the current issue of Week in Review>>
Last Updated on Monday, 29 October 2018 11:11
Special Care Unit Wins South Florida HIMSS Innovation Award for BlueBeak Technology Created by Centric Consulting Print E-mail
Written by FHInews   
Saturday, 27 October 2018 06:49
Ft. Lauderdale based Special Care Providers was recently awarded the South Florida HIMSS Innovation Award for implementing Centric Consulting’s BlueBeak technology, which has significantly enhanced the level of care patients receive within their Special Care Unit (SCU). The South Florida HIMSS Chapter honored Special Care Providers with the award at the 2018 IntegraTe conference on October 2, 2018. The award recognizes providers for healthcare technology innovation in South Florida, taking into consideration the direct correlation between an organization’s IT initiative and accomplishment or a documented organizational objective.

Special Care Providers partnered with Centric Consulting, which developed BlueBeak, to improve their “high-touch” multi-disciplinary model of care by using beacon technology to monitor staff interaction with patients, encouraging and rewarding staff for quality patient care. The innovative technology offers real-time monitoring and visualization of patient care and creates the statistical foundation for future improvements. Each SCU staff member is issued a specialized badge and each patient bed is equipped with a beacon reader. BlueBeak uses Bluetooth to communicate between the badge and beacon reader, providing instant feedback on patients in need of service. The data collected is imported into an intuitive, custom dashboard that provides feedback and statistical data for future care initiatives.

BlueBeak’s beacon technology has improved SCU patient outcomes, reduced costs and improved services provided. Early results show ventilator weaning rates exceeding 80 percent (much higher than the national average), decannulation rates have exceeded 63 percent, and there has been a nearly 400% increase in subsequent discharges home. In addition, readmission rates have reduced to nearly 6 percent, compared to an average of 30 to 60 percent at other hospitals.
Last Updated on Saturday, 27 October 2018 15:12
Study reveals health benefits of exercise Print E-mail
Written by FHI's Week in Review   
Monday, 22 October 2018 13:29
Wayne Drash reports for CNN on Oct. 20, 2018:
We've all heard exercise helps you live longer. But a new study <posted to JAMA> goes one step further, finding that a sedentary lifestyle is worse for your health than smoking, diabetes and heart disease. Dr. Wael Jaber, a cardiologist at the Cleveland Clinic and senior author of the study, called the results "extremely surprising." 
Read more in the current issue of Week in Review>>
Last Updated on Monday, 22 October 2018 13:33
Total diet replacement programs are effective for treating obesity Print E-mail
Written by Medical Xpress   
Friday, 05 October 2018 14:32
Replacing food with a diet of soups, shakes and bars starting at 810 calories per day alongside regular sessions with a counselor is a safe and clinically effective way to treat obesity in primary care, finds a study from Oxford University researchers. Total diet replacement programs are not generally funded by the NHS in England but the authors of this study, published in the BMJ, suggest that there is now enough evidence for these programs to be one of the treatments recommended for people who are obese.
Read More
Last Updated on Friday, 05 October 2018 14:59
Studies in Healthy Older People Aim To Prevent Alzheimer's Print E-mail
Written by Marilynn Marchione | AP   
Tuesday, 02 October 2018 12:16
It may be too late to stop Alzheimer's in people who already have some mental decline. But what if a treatment could target the very earliest brain changes while memory and thinking skills are still intact, in hope of preventing the disease? Two big studies are going all out to try. Clinics throughout the United States and some other countries are signing up participants - the only studies of this type enrolling healthy older people.
"The excitement in the Alzheimer's field right now is prevention," said Dr. Eric Reiman, executive director of the Banner Alzheimer's Institute in Phoenix, which is leading the work.
Science so far has failed to find a drug that can alter the progression of Alzheimer's, the most common form of dementia; 146 attempts have failed over the last decade, a recent industry report found. Even drugs that help remove the sticky plaques that clog the brains of people with the disease have not yet proved able to stave off mental decline. It may be that they were tried too late, like lowering cholesterol after someone has suffered a heart attack whose damage can't be undone, according to Dr. Reiman.
Read More
Last Updated on Monday, 19 November 2018 17:52
<< Start < Prev 1 2 3 4 5 6 7 8 9 10 Next > End >>

Page 10 of 78

Website design, development, and hosting provided by